The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Medifast Inc

NYSE: MED
Last

(U.S.) $32.57

Today's change+0.56 +1.75%
Updated December 19 4:11 PM EST. Delayed by at least 15 minutes.
 

Medifast Inc

NYSE: MED
Last

(U.S.) $32.57

Today's change+0.56 +1.75%
Updated December 19 4:11 PM EST. Delayed by at least 15 minutes.

Medifast Inc Hits New 20-day High

Medifast Inc closed up sharply Friday, rallying (U.S.)$0.56 or 1.75% to (U.S.)$32.57 and setting a new 20-day high. Over the last five days, shares have gained 4.36% and 24.65% year to date. Shares have outperformed the S&P 500 by 14.87% during the last year.

Key company metrics

  • Open(U.S.) $32.00
  • Previous close(U.S.) $32.01
  • High(U.S.) $32.70
  • Low(U.S.) $31.31
  • Bid / Ask-- / --
  • YTD % change+24.65%
  • Volume337,586
  • Average volume (10-day)162,900
  • Average volume (1-month)139,549
  • Average volume (3-month)144,692
  • 52-week range(U.S.) $24.04 to (U.S.) $36.06
  • Beta1.33
  • Trailing P/E19.56×
  • P/E 1 year forward18.14×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.66
Updated December 19 4:11 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.85%

Based on its net profit margin of 6.85%, Medifast Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.85%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Food Processing
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue74818777
Total other revenue--------
Total revenue74818777
Gross profit55606458
Total cost of revenue19212320
Total operating expense68737870
Selling / general / administrative49535551
Research & development--------
Depreciation / amortization------0
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income6797
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax7997
Income after tax5665
Income tax, total2331
Net income5665
Total adjustments to net income--------
Net income before extra. items5665
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items5665
Inc. avail. to common incl. extra. items5665
Diluted net income5665
Dilution adjustment--0----
Diluted weighted average shares13131314
Diluted EPS excluding extraordinary itemsvalue per share0.390.440.450.39
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.390.440.450.39